RxDoctor Payments Data

Jeremy Richmon, MD

Otolaryngology · Boston, MANPI 1871658369

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (56.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 94.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2022 at $3,687 and has fallen 86.4% since, to $500 in 2025.

$4,439in general payments, 2019–2025

Across 12 payments — averaging $369.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • Intersect ENT, Inc.$126
  • Baxter Healthcare$125

What the payments were for

  • Speaking & faculty fees$50011%
  • Travel & lodging$1,18727%
  • Food & beverage$2526%
  • Education$2,50056%

General payments by program year

19
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Intuitive Surgical10$4,187
Intersect ENT, Inc.1$126
Baxter Healthcare1$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,439 in reported general payments places this provider in the 85th percentile of 298 otolaryngology providers in Massachusetts.

See all otolaryngology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$241,474
Medicare patients
443
Services billed
1,242

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole40$474
Triamcinolone Acetonide11$226
Azelastine Hcl11$171

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →